These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5853360)

  • 41. Chemotherapeutic trials in leprosy. 6. Pilot study of the riminophenazine derivative B.663 in low dosage (100 mgm. twice weekly) in the treatment of lepromatous leprosy.
    Waters MF
    Int J Lepr Other Mycobact Dis; 1968; 36(4):391-9. PubMed ID: 4898403
    [No Abstract]   [Full Text] [Related]  

  • 42. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 44. [Current status of the medical treatment of Hansen's disease].
    Coudert J; Lu HT
    J Med Lyon; 1972 Sep; 53(232):1047-54. PubMed ID: 4638074
    [No Abstract]   [Full Text] [Related]  

  • 45. Lymphocytotoxins in leprosy.
    Kaur I; Vaishnavi C; Kaur S; Sharma VK; Ganguly NK; Kohli M; Wangoo A
    Indian J Lepr; 1989 Apr; 61(2):164-8. PubMed ID: 2787369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 47. [Symptomatic treatment of the leprotic reaction with hydroxychloroquine sulfate].
    Proença N
    Rev Bras Leprol; 1965; 33(1):35-44. PubMed ID: 5873236
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment defaulters in leprosy: a retrospective study of 42,000 cases.
    Koticha KK; Nair PR
    Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):50-5. PubMed ID: 571850
    [No Abstract]   [Full Text] [Related]  

  • 49. A comparative study between 12 and 24-dose therapeutic regimens for multibacillary leprosy patients.
    Sales AM; Sabroza PC; da Costa Nery JA; Duppre NC; Sarno EN
    Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):320-3. PubMed ID: 15485290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Leprosy in Guadeloupe 1980-1990: development and management in the general hospital].
    Strobel M; Gros de Beler A; Arnaud JP; Sibille G
    Bull Soc Pathol Exot; 1992; 85(1):22-5. PubMed ID: 1596953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leprosy in Albania.
    Nakuci M
    Indian J Lepr; 1992; 64(3):385-8. PubMed ID: 1431328
    [No Abstract]   [Full Text] [Related]  

  • 52. Letters to the editor: new indigenous drug in the treatment of lepra-reaction and lepromatous leprosy.
    Behl PN
    Indian J Dermatol; 1967 Apr; 12(3):120-8. PubMed ID: 6065798
    [No Abstract]   [Full Text] [Related]  

  • 53. Dapsone in wheat flour as a possible method of therapy in leprosy. A laboratory report.
    Naik SS; Pandya SS
    Lepr India; 1977 Oct; 49(4):516-20. PubMed ID: 604659
    [No Abstract]   [Full Text] [Related]  

  • 54. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leprosy--a disease of the Schwann cell.
    Antia NH
    Lepr India; 1982 Oct; 54(4):599-604. PubMed ID: 6763963
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum lysozyme in leprosy.
    Naik SS; Gurnani S
    Lepr India; 1980 Oct; 52(4):501-7. PubMed ID: 7464056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controlled follow-up assessment of the effect of thalidomide upon the ulnar nerve in leprosy.
    Magora A; Rozin R; Sagher F; Sheskin J; Gonen B
    Int J Lepr Other Mycobact Dis; 1971; 39(4):863-71. PubMed ID: 5170475
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of camoquin in the treatment of reaction case of leprosy.
    Chowdhury AD; Manna K
    Indian Med J; 1965 Nov; 59(11):245-8. PubMed ID: 5848315
    [No Abstract]   [Full Text] [Related]  

  • 59. Study of compliance of the patients in leprosy control programme in an urban slum.
    Kartikeyan S; Bhalerao VR
    J Postgrad Med; 1986 Jul; 32(3):127-30. PubMed ID: 3795123
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of an immunomodulant, isoprinosine, in multibacillary leprosy. Preliminary study].
    Saint-André P; Ferracci C; Ridel PR; Baquillon C; Boucher P
    Acta Leprol; 1982; (86-87):113-29. PubMed ID: 6183917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.